As shown in Figure 1, IHC staining results showed that in 125 non-tumor liver samples in the TMA, 118 samples showed positive staining for GLS2 (+; ≥10% positive staining cells) and 7 samples showed weak staining for GLS2 (±; <10% positive staining cells). The gene discussed is GLS2; the disease is neoplasm.